Evidence Hub

Serum BMP8B levels in women with polycystic ovary syndrome: a case-control study

Ren XP, Liu M, Hao WJ, Xue HL, Li Y, Wei JX, Song J

Ginekologia polska, 2026

Abstract

OBJECTIVES: To investigate serum brown adipokine BMP8b levels in polycystic ovary syndrome (PCOS) and their association with metabolic parameters.

MATERIAL AND METHODS: The present cross-sectional analysis enrolled 80 PCOS-diagnosed women alongside 40 matched controls. Serum levels of BMP8b, lipids, glucose metabolism, and reproductive hormones were assayed. Insulin resistance was assessed by HOMA-IR.

RESULTS: Patients with PCOS exhibited significantly lower serum BMP8b levels compared to controls (43.11 ± 13.09 vs 106.45 ± 52.32, p < 0.001). In the PCOS group, BMP8b showed significant negative correlations with both BMI (r = -0.240, p < 0.05) and HOMA-IR (r = -0.246, p < 0.05), while in the control group, BMP8b was negatively correlated with TG (r = -0.436, p < 0.05). Notably, pooled analysis of all subjects revealed a strong inverse correlation between BMP8b and total testosterone (T) (r = -0.468, p < 0.001).

CONCLUSIONS: Reduced BMP8b in PCOS correlates with metabolic dysfunction, suggesting brown adipose tissue as a potential therapeutic target.

How strong is the evidence?

Evidence Hub reads this as a case-control, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free